ArticleEpidemiology and health2015
Analysis of survival data in thalassemia patients in Shiraz, Iran.
Article in Epidemiology and health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Article
- Mortality and complications in Omani patients with beta-thalassemia major: a long-term follow-up study.Acta bio-medica : Atenei Parmensis · 2023Article
- Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management.Biology · 2022Review
- Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective.Orphanet journal of rare diseases · 2021Article
- Changing patterns in the epidemiology of β-thalassemia.European journal of haematology · 2020Review
- Eradication of hepatitis C virus infection in thalassemia patients in Iran using various treatment strategies.Journal of virus eradication · 2020Article
- Marital status and paternity in patients with Transfusion- Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries.Acta bio-medica : Atenei Parmensis · 2019Article
- Treatment Status of Patients with B-Thalassemia Major in Northern Iran: Thalassemia Registry System.Iranian journal of public health · 2019Article
- Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine.BMC hematology · 2019Article
- The survival rate of patients with beta-thalassemia major and intermedia and its trends in recent years in Iran.Epidemiology and health · 2018Article
- Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study.Journal of public health research · 2017Article
- Survival analysis of thalassemia major patients using Cox, Gompertz proportional hazard and Weibull accelerated failure time models.Medical journal of the Islamic Republic of Iran · 2017Article
- Poor quality of life as a predictor of survival among thalassemia patients in Iran.Epidemiology and health · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe survival rate of thalassemia patients has not been conclusively established, and the factors associated with survival remain unclear. This study aimed to determine the survival rate of thalassemia among patients in southern Iran and to identify the factors associated with mortality from thalassemia.
methodsThis retrospective cohort study was conducted based on a retrospective review of the medical records of 911 beta-thalassemia patients in 2014. Data analysis was conducted using the Kaplan-Meier method and Cox regression analysis.
resultsOverall, 212 patients (23.3%) died, and 26.8% had thalassemia intermedia. The 20-year, 40-year, and 60-year survival rates were 85%, 63%, and 54%, respectively. Both crude and adjusted analyses found that education, marital status, ferritin levels, and comorbidities were related to mortality.
conclusionsSociodemographic and hematological factors were found to be significantly associated with the survival rate of thalassemia. Addressing these factors may help healthcare providers and physicians to provide the best possible care and to improve the survival rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.